15 August 2016

Oxford BioDynamics To Conduct ALS Biomarker Program In Malaysia

UK biotechnology company Oxford BioDynamics, which has a subsidiary in Penang, Malaysia, is expanding its biomarker discovery program for diagnostic tests for amyotrophic lateral sclerosis (ALS). ALS is a neurodegenerative disease that affects the function of nerves and muscles and shortens lifespan.  This part of the research program will recruit ALS patients and healthy subjects in Malaysia and will be overseen by Professor Goh Khean Jin, head of neurology at the University of Malaya. Source: Asian Scientist 15/8/2016

My IChemE

IChemE is a registered charity in England & Wales (214379), and a charity registered in Scotland (SC 039661).